Search Results 651-660 of 15917 for clindamycin

  1. Ofatumumab (intravenous route, subcutaneous route) - Mayo Clinic

    Ofatumumab injection is used in combination with chlorambucil to treat a type of cancer of the white blood cells called chronic lymphocytic leukemia (CLL) in ...

  2. Gallium citrate ga 67 (intravenous route) - Mayo Clinic

    Gallium citrate Ga 67 injection is used to help your doctor diagnose if you have certain types of cancer, such as Hodgkin's disease, lymphoma, or lung cancer.

  3. Electrophysiological Biomarkers for Parkinson's Disease - Mayo Clinic

    This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...

  4. A Study to Assess Reproductive History in Kidney Donors - Mayo Clinic

    The purpose of this study is to analyze the effect of parity, menopause and reproductive lifespan on kidney structure and function. Participation eligibility.

  5. Endometriosis - Symptoms and causes - Mayo Clinic

    Symptoms · Painful periods. Pelvic pain and cramping may start before a menstrual period and last for days into it. · Pain with sex. Pain during or after sex is ...

  6. Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants with Chronic Cough - Mayo Clinic

    The purpose of this study is to evaluate the sasfety and effectiveness of MK-7264 in reducing cough frequency as measured over a 24-hour period. Participation ...

  7. Expanded Access Program with Tirasemtiv for the Treatment of Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    About this study. The purpose of this study is to make Tirasemtiv available to a limited group of patients who suffer from ALS, who participated in CY 4031 ...

  8. Sirolimus protein-bound (intravenous route) - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  9. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    The purpose of this study is to assess whether minimal residual disease (MRD) driven finite calabrutinib plus venetoclax (AV) treatment is non-inferior to MRD- ...

  10. A Study to Evaluate APG2575 Combined with Novel Therapeutic Regimens To Treat Subjects with Relapsed or Refractory Multiple Myeloma and Immunoglobulin Light Chain Amyloidosis - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated ...